Tuesday - October 20, 2026

Intratumoral Cancer Therapies Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2025-2034 | DelveInsight

The Key Intratumoral Cancer Therapies Companies in the market include – Nanobiotix, Replimune, Sirnaomics, OncoSec Medical, Daiichi Sankyo, Amgen, Merck & Co (Viralytics), Moderna Therapeutics, Idera Pharmaceuticals, Philogen, Lokon Pharma, Hookipa Biotech, Vyriad, Intensity Therapeutics, and others. (Albany, US), October … Continue reading →